London, UK -- (SBWIRE) -- 10/05/2017 -- Growth boosting factors
The global temperature controlled packaging market has witnessed a strong growth over the past few years as pharmaceuticals and drug monitoring authorities across geographies are focussing on framing stringent legislations to handle and distribute pharmaceutical products. These regulations are prominent and comparatively stringent in developed countries as compared to the rest of the world. Another factor driving this market is the critical risk of damage to products and anti-counterfeiting during transport in pharmaceutical and biotechnology supply chains. To eliminate this, regulations are being implemented in the U.S and Europe to harmonise manufacturing, processing and distribution of temperature-sensitive pharmaceutical products.
Download Sample Report@ https://www.futuremarketinsights.com/reports/sample/rep-gb-5076
Also, demand for biologics is anticipated to outpace overall pharmaceuticals spending growth, and biologics are expected to represent 20% growth in the near future. Novel therapies, new drug development and increasing clinical trials catapult demand for cold chain packaging solutions for pharmaceuticals. Global demand for temperature-sensitive vaccines is anticipated to grow by 6%–7% annually.
International organisations such as World Health Organization (WHO) are continuously focussing on reducing wastage of vaccines across the globe. The pharmaceuticals supply chain is complex and various minute requirements need to be addressed at the time of transportation and delivery. Pharmaceutical products require different temperature ranges while shipping to warehouses, and also proper compilation as well as sorting while delivering to respective pharmacies.
Passive cooling is the most economically viable method for pharmaceutical products, considering the low volumes. Also, distribution of products with varying temperature range to different pharmacy locations is a challenge that can be addressed through effective cold chain packaging.
Developing countries such as Brazil, India, and China are potential markets for pharmaceuticals. Increasing investment in the pharmaceuticals industry has been witnessed in developing countries due to higher demand for medications and existing production cost advantages in these countries. Also, number of clinical trials in countries such as India has increased exponentially over the last few years. These factors collectively result in increased demand for temperature controlled packaging solutions.
Restraints faced by the industry are high costs associated with temperature controlled pharmaceutical packaging. Need for better handling of temperature sensitive pharmaceutical products has resulted in increased research for more advanced temperature controlled packaging insulation materials such as VIP, PCMs, and sheep wool. Recent trends observed in the temperature controlled packaging solutions market is the focus of pharmaceutical manufacturers on outsourcing packaging and transportation of temperature sensitive products to third party logistics companies. 3PLs offer customised end-to-end solutions for various products requiring different temperature ranges and type of handling. Strong distribution network of most 3PLs enables pharmaceutical companies to access new consumer base across the globe.
Obtain Report Details @ https://www.futuremarketinsights.com/reports/temperature-controlled-pharmaceutical-packaging-solutions-market-092017
To cope with growing regulatory pressure and reduce transportation costs, service providers are focussing on the use of reusable packaging rather than one-way (disposable) systems. Reusable packaging reduces usage of refrigerants and insulation materials that are linked with ozone depletion and global warming. Use of reusable insulated containers for multiple transportation is also significantly cost effective.
Temperature controlled packaging solutions providers are rapidly expanding their rental businesses and are comparatively less focussed on the sales of their products. Temperature-controlled containers are very expensive to own and operate. This dissuades logistics and cargo shipping companies from owning and operating these containers.
The temperature controlled packaging for pharmaceutical market is segmented by product type into insulated shippers, insulated protective shippers, insulated containers and others segment. Among the insulated shippers market, it is segmented into panels and envelopes, EPS foam container, fiberboard and PUR. Further, insulated containers is segmented into chest style and upright style.
By application type, the temperature controlled packaging for pharmaceutical market is segmented into frozen, chilled and ambient segment.
On the basis of region, APEJ is anticipated to dominate the global temperature controlled packaging for pharmaceutical market. North America and Western Europe regions are anticipated to gain a share of 26.5% and 21.2% respectively by the end of 2027. This is followed by Eastern Europe, which is expected to hold a share of 6.4% by the end of 2027.